Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Viscosupplementation referred as the injection of thick fluid called hyaluronate which is injected into the knee joint. Hyaluronate is a natural substance present in the joint fluid that assist in joint lubrication and allows the smooth movement of cartilage covered articulating surface of joint. However, patient suffering from Knee Arthritis, Hip Osteoarthritis has increasing requirement for hyaluronate injection which helps in improving the lubricating properties of synovial fluid, reducing the pain the osteoarthritis of knee and improve mobility and provide higher comfortable level of activity. The growing burden of Knee Arthritis, Hip Osteoarthritis across the North America, increasing awareness for treatment which can help to reduce pain and swelling has led the growth of market in region. Furthermore, increasing spending in healthcare is expected to fuel the growth of North America market in viscosupplementation.
The factors driving the market growth in North America are increasing incidence of knee osteoarthritis in the region has led the rising demand viscosupplementation market. For instance according to CDC, OA affects over 32.5 million US adults thereby the region’s rising cases in knee osteoarthritis is expected to increasing the demand for market over the forecast period. Besides, integration of proprietary technology to offer significant opportunities for the market growth. Additionally, rising old age population is the key factor propelling the demand for market in the North America region.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the North America viscosupplementation market. In addition, complete analysis of changes on the North America viscosupplementation market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market.
The viscosupplementation market comprises of different market segment like product, hyaluronic acid type, application, end-user and country
By product, the viscosupplementation market includes key segment of single injection, three injection, and five injection. In North America region, the three injection is expected to register major market share during the forecast period. The segment is driven by rising requirement for three injection to reduce the symptoms of knee arthritis, hip osteoarthritis has led the demand for segment to huge extend. Also, the injection provide long term, non-systemic pain relief for knee osteoarthritis, and has low rate of complications which is expected to fuel the growth of market during the estimated time period. Likewise, single injection is anticipated to witness growth at highest pace during due to rapid adoption of segment in the region.
The viscosupplementation market, includes different hyaluronic acid type like stabilized hyaluronic acid, standard hyaluronic acid. Stabilized hyaluronic acid has gained major market in the North America region. The factors contributing in the market growth are different benefits provided by stabilized hyaluronic acid like reducing pain and swelling is expected to increasing the demand for market in the region. Also, standard hyaluronic acid is expected to grow at moderate pace during the estimated time period. The new innovation, research for standard hyaluronic acid is the key factor boosting the growth of segment.
The viscosupplementation market finds its major application in knee arthritis, hip osteoarthritis and others. In North America market for viscosupplementation, by application, knee arthritis has increasing demand for market attributing to rising population with knee arthritis, growing geriatric aging population, injuries of knees among sports people has significantly increased the growth of market. In addition, growing awareness for treatment has boosted the demand for market. Similarly, hip osteoarthritis is anticipated to hold second position in market owing to growing prevalence of obesity, rising cases of hip osteoarthritis in different old age group population which has led the requirement for viscosupplementation market in North America region.
The viscosupplementation market has different end user like hospitals, orthopedic clinics/ambulatory surgical centers (ascs). Hospitals leads in the North America viscosupplementation market owing to developed healthcare facilities for treating the patient. Besides, rising patient inflow with knee arthritis, hip osteoarthritis for treatment has fuelled the growth of segment. Additionally, healthcare spending and awareness for treatment like viscosupplementation is accelerating the demand for market. Furthermore, orthopedic clinics/ambulatory surgical centers (ascs) is expected to witness new growth avenue as the segment majorly provide treatment based on patient time management in one days with different viscosupplementation market.
North America viscosupplementation market is studied for the following countries like United States, Canada and Mexico. The demand for viscosupplementation in region is due to rising burden of knee arthritis, hip osteoarthritis and others in the region. Based on country, the United States is expected to gain major market share during the estimated time period. The presence of key manufacturer in the country and rising demand for minimally invasive surgery, high prevalence of knee arthritis, hip osteoarthritis has increased the growth of market in the country. Additionally, Canada followed by Mexico is anticipated to witness the growth at significant pace during forecast period.
The key players in viscosupplementation market are Anika Therapeutics, Inc. , Aptissen SA , Bioventus, Singclean ,CROMA-PHARMA, Dr. Reddy's Laboratories, Ferring Pharmaceuticals, Fidia Pharma USA Inc , BioPolymer GmbH & Co. KG, Johnson & Johnson, LG Life Sciences, LABRHA International , Virchow biotech, Sun Phrama , Mylan, OrthogenRx , Roche, Ettsons , Sanofi Genzyme, Seikagaku Corporation, Smith & Nephew, Stellar Phamaceuticals Inc, Tecnofarma S.A., TRB Chemedica International, Wellchem Pharmaceuticals Pte Ltd., Zimmer Biomet
February 2020: Anika therapeutics Inc. acquired Arthosurface, which is a leading privately-held provider of joint surface and preservation solutions for active patients. This acquisition will significantly enhance the commercial capabilities in the U.S. and expand the product platform strategy.
December 2019: Fidia pharma USA Inc. introduced TRILURON in the U.S. It is a 3 injection product for the treatment of osteoarthritis. It also completes the HA viscosupplement portfolio offering for Fidia Pharma USA Inc.
June 2019: Sun Pharma had announced late-breaking phase 2 Data Showing Potential of ILUMYA (tildrakizumab-asmn) to improve joint and skin symptoms of psoriatic arthritis. It is approved in the U.S. for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy and is being investigated for psoriatic arthritis.
January 2019: Bioventus launched Durolane, single injection joint fluid osteoarthritis treatment in Malaysia and selected Athrotech as its exclusive distribution partner for market. Arthotech is beneficial for Bioventus as it continues to grow in Asia and expand the reach and Malaysia is the fourth market in Asia where Durolane is introduced.
The report analyses the viscosupplementation market based on by product, hyaluronic acid type, application, end-user and country. By product, the viscosupplementation market includes key segment of single injection, three injection, and five injection. In North America region, the three injection is expected to register major market share during the forecast period. The viscosupplementation market, includes different hyaluronic acid type like stabilized hyaluronic acid, standard hyaluronic acid. Stabilized hyaluronic acid has gained major market in the North America region. The viscosupplementation market finds its major application in knee arthritis, hip osteoarthritis and others. In North America market for viscosupplementation, by application, knee arthritis has increasing demand for market attributing to rising population with knee arthritis, growing geriatric aging population, injuries of knees among sports people has significantly increased the growth of market. The viscosupplementation market has different end user like hospitals, orthopedic clinics/ambulatory surgical centers (ascs). Hospitals leads in the North America viscosupplementation market owing to developed healthcare facilities for treating the patient. North America viscosupplementation market is studied for the following countries like United States, Canada and Mexico.
Why to buy this report:
